Abstract: This letter proposes a new modeling framework for stability assessment in grid-forming virtual synchronous generator. Specifically, the mechanism of self-stability and induced-stability have ...

The Food and Drug Administration Monday unveiled the details of a new policy designed to make it easier and quicker for patients with very rare diseases to get cutting-edge treatments. The new ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Panelists discuss how the muscarinic pathway of xanomeline/trospium offers a safer, nondopaminergic approach to schizophrenia care. Panelists discuss how xanomeline/trospium chloride introduces a ...

Researchers discovered that a long-misunderstood protein plays a key role in helping chromosomes latch onto the right “tracks” during cell division. Instead of acting like a motor, it works more like ...

The decision at the COP30 climate talks to create a Belém Action Mechanism (BAM) for Just Transition is a major victory for workers and their trade unions. For the first time ever workers and their ...

The first step in a 12-step program is for the addict to admit that they have a problem, because most addicts are in denial about their addictions. And, as my clinical supervisor observed when I was ...

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory pathway that could trigger a seismic shift in how bespoke gene editing therapies ...